Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of Approximately $220 Million of Common Stock

World News: . []

SAN CARLOS Calif Oct 12 2018 GLOBE NEWSWIRE -- Iovance Biotherapeutics IncNasdaqIOVA Iovance or Company a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte TIL techn ology, ...

More news and information about Iovance Biotherapeutics, Inc.

Published By:

Globe Newswire: 12:45 GMT Friday 12th October 2018

Published: .

Search for other references to "iovance" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us